Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 6, 2022British Journal of HaematologyOpen Access

The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains

View Full Paper
Ask AI
Bookmark
Share

Authors

MEMacy L. EarlyELElizabeth A. LintonABAllison Bosch

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Early et al. (2022) studied this question.

synapsesocial.com/papers/6a71fe90ac440176ef2a7589https://doi.org/10.1111/bjh.18188
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neurocognitive deficits in children with sickle cell disease: a comprehensive profile2010 · 97 citations
  2. 2Cognitive Screening Tests Versus Comprehensive Neuropsychological Test Batteries: A National Academy of Neuropsychology Education Paper†2017 · 215 citations
  3. 3Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease2020 · 18 citations
  4. 4Cerebrovascular reserve capacity is impaired in patients with sickle cell disease2009 · 77 citations
  5. 5American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults2020 · 440 citations